39
Femoral shaft fractures are common and severe injuries that typically occur alongside 40 other complex, high-energy injuries in the poly-traumatized patient. Femur fractures can yield 41 extensive bleeding and muscle injury of the thigh, and have a high worldwide burden; occurring 42 at a rate between 14 and 42.5 /100,000 person years, with approximately 1 in 10 road traffic 43 accidents worldwide involving a femoral shaft fracture treated by surgery 1 . Additionally, there is 44 a significant disparity of burden for diaphyseal femur fractures, with 91% occurring in lower 45 middle class income countries, with the majority affecting younger males. 2 
46
To help mitigate the effects of ongoing blood-loss, worsening inflammation and pain 47 from the unstable fracture ends, femoral shaft fractures require urgent management using either 48 an early total-care or damage-control orthopaedics approach 3, 4, 5 . Associated injuries, markers of 49 resuscitation, and overall patient stability guide operative decision making on timing of surgical 50 intervention 6 . Definitive internal fixation using reamed, locked intramedullary nailing (IMN) has 51 become the standard of care in the adequately resuscitated patient 7 as it provides fracture 52 stability while facilitating nursing care and patient mobilization 8,9 . Multiple femoral IMN 53 techniques exist, however most femoral shaft fractures can be treated with an antegrade nail 54 using either supine (fracture table) or lateral (free-leg drape) positioning 10, 11 . Fracture pattern, 55 patient characteristics, associated injuries, hospital-resources, availability of assistants and 56 surgeon preference may all play a role in determining which positioning option is chosen. There 57 are advantages and disadvantages to each, and little clinical evidence exists to aid in decision-58 making.
59
This research group completed a systematic review of the literature on patient 60 positioning during antegrade nailing of femur fractures in the last year (Journal # OTAI-18-61 00048). The review revealed only three non-prospective studies on this specific topic, 12, 13 . This 62 clearly leaves much uncertainty surrounding optimal patient positioning during the definitive 63 treatment of these critical injuries.
64
For antegrade IMN, supine positioning is most commonly accompanied by a fracture (or 65 traction) table. This surgical table secures the injured extremity and maintains it in a set position 66 throughout the procedure using an adjustable amount of mechanical traction applied though a 67 boot or skeletal traction pin, while using posts and straps to provide counter traction. While this 68 may do an excellent job at obtaining length, it may be easy to mal-reduce comminuted fractures 69 if keen attention is not paid to other anatomic reference points that help restore alignment and 70 rotation 14 . This is vital, as the main reason for malpractice litigation following a femoral shaft 71 fracture is failing to restore anatomic length, alignment and rotation 15 195 This allows for the patient to be approach for participation postoperatively. Patients will be 196 approached after surgery. The trial will be explained to patients with emphasis that there will be 197 no negative implications should they choose not to be involved. A standardized consent form 198 will be provided to patients which will be signed and stored securely by the research 199 coordinator. As part of the randomization, patients will also be randomized to inclusion or 200 exclusion from gait analysis studies at one year, with 20% of patients participating in gait 201 analysis. This second randomization will be done upon completion of follow up at one year and 202 it would be included in the initial consent form. We will obtain ongoing consent from patients at 203 every follow-up appointment and patients will have the option to withdraw consent. In order to Table   213 The supine fracture table group will be positioned supine in the operating room, on a fracture 214 table. The operative leg will be placed in a boot, attached to the traction limb. The non operative 215 leg will either be scisorred away from the operating area in a traction boot (without traction 216 placed), or placed in a stirrup at 90 degrees of hip flexion in hemilithotomy. A central post will be 217 used to prevent patient movement during application of traction, and all bony prominences will 218 be padded. Fluoroscopy will be obtained through standard practices.
220 Lateral Positioning, Free drape
221 The lateral positioning group will be placed in lateral position after anaesthetic has been 222 provided. A beanbag will be placed below the patient, and the patient will be safely turned to a 223 lateral position ( Figure 1, Figure 2 ). The beanbag will be inflated, the leg will be prepped, and a 224 free drape will be applied. No traction will be used. Alternatively, some participating sites may 225 use stulberg positioners rather than an inflatable beanbag, based on hospital preference. We will assess the wound integrity at 2 week, 1 month and 6 month follow up. Any wound 316 dehiscence, or concern with appearance or superficial infection will be documented, as well as 317 requirement to treat with oral or parenteral antibiotics.
318
319 Satisfaction with pain control 320 We will ask patients to rate their satisfaction with pain control using a 5-point Likert scale with 321 options ranging from "poor" to "excellent".
323 Systemic and local adverse events
324 An adverse event (AE) is any symptom, sign, illness or experience that develops or worsens in 325 severity during the course of the study.
327 Study Visits and Timelines
328 Patients will be screened for eligibility and randomized at hospital admission. We will collect 329 study data at the following timepoints:
335 All visits after the baseline visit can be completed in-clinic or by telephone with additional 336 information collected from medical records, as needed. The sample size for the pilot trial is based primarily on feasibility objectives. We determined a 375 priori that the study would be feasible if loss to follow-up is less than 10%. We believe that our 376 loss to follow-up will be about 5%; therefore, using the confidence interval approach suggested 377 by Thabane et al, we require 200 patients to achieve a 5% margin of error (which will generate a 378 confidence interval that excludes 10%). 384 the study will be summarized using a flow diagram. Participant demographics, medical history, 385 surgical details, and peri-operative details will be summarized by treatment group using 386 descriptive summary measures: expressed as mean, standard deviation and confidence 387 internvals (95%), or median and interquartile range for continuous variables, depending on the 388 distribution, and number and percent for categorical variables. Statistical significance will be 389 defined as a P value <0.05, and all statistical testing will be 2 -tailed. We plan to include the 390 data from our pilot in the definitive trial if we are able to demonstrate feasibility and there are no 391 important changes to our patient population, intervention, or outcome measures. All patients 392 who are enrolled in the trial and randomized will be included in the analysis, regardless of level 393 of adherence to the intervention, or any other deviation from protocol. We will not impute for 394 missing data in this pilot trial.
396 Primary Analysis
397 Point estimates of recruitment and feasibility events, including adherence to protocol and follow-398 up rate at one-year, as proportions with 95% CIs will be presented. The pilot study results will 399 be evaluated to identify recruitment issues, data management issues, and inform anticipated 400 follow-up rates. 
